<?xml version="1.0" encoding="UTF-8"?>
<wcm:root xmlns:wcm="http://www.stellent.com/wcm-data/ns/8.0.0">
  <wcm:element name="MainContent">&lt;table id="schedule" border="0" cellspacing="0" summary="This table shows the date, time, and location of the meeting" cellpadding="2" style="width: 100%"&gt;&lt;tbody&gt;&lt;tr&gt;&lt;th id="a1" bgcolor="#cccccc" valign="top" width="10%" align="left"&gt;Center&lt;/th&gt;&lt;th id="a2" bgcolor="#cccccc" valign="top" width="25%" align="left"&gt;Date&lt;/th&gt;&lt;th id="a3" bgcolor="#cccccc" valign="top" width="25%" align="left"&gt;Time&lt;/th&gt;&lt;th id="a4" bgcolor="#cccccc" valign="top" width="40%" align="left"&gt;Location&lt;/th&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="10%" headers="a1"&gt;OC&lt;/td&gt;&lt;td valign="top" width="25%" headers="a2"&gt;September 15, 2015&lt;/td&gt;&lt;td valign="top" width="25%" headers="a3"&gt;4:00&amp;nbsp;p.m. &amp;ndash;&amp;nbsp;5:30 p.m.&lt;/td&gt;&lt;td valign="top" width="40%" headers="a4"&gt;&lt;p&gt;Food and Drug Administration&lt;br /&gt;via&amp;nbsp;Webcast&lt;br /&gt;&amp;nbsp;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;This meeting will be open to the public, via Webcast. To access the&amp;nbsp;Webcast link&amp;nbsp;check the Agency&amp;rsquo;s Web site at&amp;nbsp; &lt;a href="http://www.fda.gov/AdvisoryCommittees/default.htm"&gt;http://www.fda.gov/AdvisoryCommittees/default.htm&lt;/a&gt; and scroll down to the appropriate advisory committee meeting link.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Agenda&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;The Science Board will be provided with a report from the Science Looking Forward subcommittee.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Meeting Materials&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;FDA intends to make background material available to the public no later than 2 business days before the meeting. Background material is available at &lt;a href="http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm"&gt;http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm&lt;/a&gt;. Scroll down to the appropriate advisory committee meeting link.&lt;/p&gt;&lt;ul&gt;&lt;li&gt;&lt;a target="" href="[!--$wcmUrl('link','UCM431539')--]"&gt;Background Material&lt;/a&gt;&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;&lt;strong&gt;Public Participation&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee.&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Written submissions may be made to the contact person on or before September 8, 2015.&lt;/li&gt;&lt;li&gt;Oral presentations from the public will be scheduled between approximately 4:30 p.m. and 5:30 p.m. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before September 1, 2015.&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by September 2, 2015.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Contact Information&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;Rakesh Raghuwanshi&lt;br /&gt;Office of the Chief Scientist&lt;br /&gt;Office of the Commissioner&lt;br /&gt;Food and Drug Administration&lt;br /&gt;White Oak Bldg 1, Room 3309&lt;br /&gt;10903 New Hampshire Ave&lt;br /&gt;Silver Spring, Maryland 20993&lt;br /&gt;Phone: 301&amp;ndash;796-4769&lt;br /&gt;Fax: 301-847-3536&lt;br /&gt;E-mail: &lt;a href="mailto:rakesh.raghuwanshi@fda.hhs.gov"&gt;rakesh.raghuwanshi@fda.hhs.gov&lt;/a&gt;&lt;/p&gt;&lt;p&gt;A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency&amp;rsquo;s Web site at &lt;a href="http://www.fda.gov/AdvisoryCommittees/default.htm"&gt;http://www.fda.gov/AdvisoryCommittees/default.htm&lt;/a&gt; and scroll down to the appropriate advisory committee meeting link, or call the advisory committee information line to learn about possible modifications before coming to the meeting.&lt;/p&gt;&lt;ul&gt;&lt;li&gt;FDA Advisory Committee Information Line 1-800-741-8138&lt;br /&gt;(301-443-0572 in the Washington DC area).&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Rakesh Raghuwanshi at (301) 796-4769 at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site for procedures on public conduct during advisory committee meetings.&lt;/p&gt;&lt;p&gt;Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app.2).&lt;/p&gt;</wcm:element>
<wcm:element name="MainList1"></wcm:element>
  <wcm:element name="MainList2"></wcm:element>
  <wcm:element name="MainList3"></wcm:element>
</wcm:root>
